Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of different insulin therapy regimens in poorly controlled type 2 diabetes
2009-015760-33Phase 4Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of insulin aspart and insulin detemir in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoints: Descriptive quantitative parameter summary by treatment modality and timepoint, Arterial stiffness/compliance and 3 more. Started Oct 2009; status: active.
02
Drugs
insulin aspartinsulin detemir
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2009-015760-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015760-33.